Business Courses

MicroRNA and Epigenetics: The Research Market, Diagnostics, and Therapeutics

This Business Course is being held in Boston, USA on the 18 April 2012 at 14.00 - 17.00

Price:

Enal Razvi Managing Director, Select Biosciences Inc

Scope of this Training Course

This course is designed to provide a comprehensive analysis of the current state of the microRNA and epigenetics fields focusing upon the underlying science, emerging trends in technology development, the competitive environment, and market metrics.

microRNAs	Epigenetics
Biological Significance and Role Utility of Expression Patterns/Signatures as a Determinant for Physiological Processes as well as Disease/Pathological Situations
Technologies for Studying microRNAs and Epigenetic Modifications The Competitive Environment Market Metrics
Diagnostics Therapeutics

This training course is ideally suited for researchers involved in investigations focusing on microRNAs or epigenetic changes in biological and disease situations—both academic as well as from the industrial community. Also, this course is important for biotechnology, pharmaceutical, and related disciplines wherein industry participants—both technically focused as well as business focused—can get a solid understanding of the marketplace as well as receive the most up-to-date market data and associated materials for in-house research and business planning activities. Also, this course is recommended for investors as well as attorneys looking for a current technology and market review of this expanding field.

All attendees to this training course receive the electronic files of the presentation material on disk with full rights to use them in their internal R&D as well as business planning activities

Training Course Specific Presentation Topics

• MicroRNA Expression Profiles and Epigenetic Modifications in vivo: Biological Significance and Association with Disease Processes
• Technologies for Studying microRNA Expression Profiles and Function
• Technologies for Identifying Epigenetic Modifications
• Competitive Landscape of Research Tools and Technologies, Quantitative Market Penetrance
• Market Metrics
• Market Size
• Growth Rates
• Industry SWOT by Segment
• Association of Specific Signatures [microRNA or Epigenetic] with Specific Physiological or Pathological Events
• Cancer
• Cardiovascular Disease
• CNS Disease
• MicroRNAs as Circulating Cancer Biomarkers
• Diagnostics
• Therapeutics
• Epigenetics
• Development as Diagnostic Biomarkers
• Utility for Therapeutics Development

For more information about this training course or for group registrations, please e-mail Kathy Gray at Kathy.Gray@SelectBiosciences.com